Class 042: Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development
Class 042: Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development
Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation; Biochemical research and development; Biotechnology research; Gene therapy research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the field of gene therapy, namely, development of oligonucleotides that target more than one aspect of the RNA transcript splicing regulation machinery and process to enhance the potentiation or inhibition of that machinery and process; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation; Biochemical research and development, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Biotechnology research, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Gene therapy research, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Pharmaceutical drug development services, namely, development and design of anti-sense oligonucleotides; Pharmaceutical products development, namely, development and design of anti-sense oligonucleotides; Pharmaceutical research and development, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Research and development in the field of RNA-targeted drugs, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Research and development in the field of gene therapy, namely, using bioinformatics to develop knowledge of the RNA transcript splicing regulation machinery to improve efficacy; Research and development in the pharmaceutical and biotechnology fields, namely, development of bioinformatics techniques for the purpose of designing anti-sense oligonucleotides; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines, namely, development and design of anti-sense oligonucleotides; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, namely, development and design of anti-sense oligonucleotides
"THERAPEUTICS"; Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Pharmaceutical preparations for the treatment of central nervous system diseases, neuromuscular diseases, metabolic diseases, and diseases related to RNA processing and translation; "ASO"; Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, neuromuscular diseases, metabolic diseases, nucleic acid-based drugs and small molecule drugs; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Biochemical research and development; Biotechnology research; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of RNA-targeted drugs; Research and development in the field of nucleic acids, biologics, central nervous system diseases, metabolic diseases, and small molecule drugs; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Class 036: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Class 042: Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development
